Effect of probiotic bacteria on induction and maintenance of oral tolerance to β-lactoglobulin in gnotobiotic mice

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 5, 2003, Pages 787-792

  Prioult, Guénolée ^a,b   Fliss, Ismail ^a   Pecquet, Sophie ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTOGLOBULIN; OVALBUMIN; PROBIOTIC AGENT; PROTEIN; UNCLASSIFIED DRUG; WHEY PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GERMFREE ANIMAL; GNOTOBIOTICS; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI; MOUSE; NONHUMAN; NUTRITIONAL TOLERANCE; PRIORITY JOURNAL; PROTEIN DIET; TREATMENT OUTCOME; WHEY;

ADMINISTRATION, ORAL; ANIMALS; BIFIDOBACTERIUM; FECES; GERM-FREE LIFE; IMMUNE TOLERANCE; INTESTINES; LACTOBACILLUS; LACTOGLOBULINS; MICE; MILK PROTEINS; PROBIOTICS;

EID: 0141452273     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.5.787-792.2003     Document Type: Article

References (35)

1. Björkstén, B., P. Naaber, E. Sepp, and M. Mikelsaar. 1999. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29:342-346.
2. Björkstén, B., E. Sepp, K. Julge, T. Voor, and M. Mikelsaar. 2001. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108:516-520.
3. Chen, Y. H., and H. L. Weiner. 1996. Dose-dependant activation and deletion of antigen specific T cells following oral tolerance. Ann. N. Y. Acad. Sci. 778:111-121.
4. Fujihashi, K., T. Dohi, P. D. Rennert, M. Yamamoto, T. Koga, H. Kiyono, and J. R. McGhee. 2001. Peyer's patches are required for oral tolerance to proteins. Proc. Natl. Acad. Sci. USA 98:3310-3315.
5. Fuller, R. 1991. Probiotics in human medicine. Gut. 32:439-442.
6. Ibnou-Zekri, N., S. Blum-Sperisen, E. J. Schiffrin, and T. von der Weid. 2003. Divergent patterns of colonization and immune response elicited from two intestinal lactobacillus strains that display similar properties in vitro. Infect. Immun. 71:428-436.
7. Isolauri, E., Y. Sütas, P. Kankaanpää, H. Arvilommi, and S. Salminen. 2001. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73(Suppl.):444S-450S
8. Kalliomäki, M., P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri. 2001. Distinct pattern of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107:129-134.
9. Kalliomäki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 357:1076-1079.
10. Karlsson, M., S. Lundin, U. Dahlgren, H. Kahu, I. Pettersson, and E. Telemo. 2001. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31:2892-2900.
11. Kato, C., K. Sato, Y. Eishi, and K. Nakamura. 1999. The influence of initial exposure timing to β-lactoglobulin on oral tolerance induction. J. Allergy Clin. Immunol. 104:870-878.
12. Kirjavainen, P. V., E. Apostolou, T. Arvola, S. J. Salminen, G. R. Gibson, and E. Isolauri. 2001. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol. Med. Microbiol. 32:1-7.
13. Kirjavainen, P. V., T. Arvola, S. J. Salminen, and E. Isolauri. 2002. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51-55.
14. Kiyono, H., J. R. McGhee, J. Wannemuehler, and S. M. Michalek. 1982. Lack of oral tolerance in C3H/HeJ mice. J. Exp. Med. 155:605-610.
15. Kweon, M. N., K. Fujihashi, J. L. VanCott, K. Higuchi, M. Yamamoto, J. R. McGhee, and H. Kiyono. 1998. Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice. J. Immunol. 160:1687-1693.
16. Lee, H.-O., S. D. Miller, S. D. Hurst, L.-J. Tan, C. J. Cooper, and T. A. Barrett. 2000. Interferon gamma induction during oral tolerance reduces T-cell migration to sites of inflammation. Gastroenterology 119:129-138.
17. Mackie, R. I., A. Sghir, and H. R. Gaskins. 1999. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69(Suppl.):1035S-1045S.
18. Maeda, Y., S. Noda, K. Tanaka, S. Sawamura, Y. Aiba, H. Ishikawa, H. Hasegawa, N. Kawabe, M. Miyasaka, and Y. koga. 2001. The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology 204:442-457.
19. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
20. Moreau, M.-C., and G. Corthier. 1988. Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice. Infect. Immun. 56:2766-2768.
21. Moreau, M.-C., and V. Gaboriau-Routhiau. 1996. The absence of gut flora, the doses of antigen ingested and aging affect the long-term peripheral tolerance induced by ovalbumin feeding in mice. Res. Immunol. 147:49-59.
22. Mowat, A. M., M. J. Thomas, S. MacKenzie, and D. M. Parrott. 1986. Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. Immunology 58:677-683.
23. Nagler-Anderson, C. 2000. Tolerance and immunity in the intestinal immune system. Crit. Rev. Immunol. 20:103-120.
24. Ouwehand, A. C., P. V. Kirjavainen, C. Shortt, and S. Salminen. 1999. Probiotics: mechanisms and established effects. Int. Dairy J. 9:43-52.
25. Pecquet, S., A. Pfeifer, S. Gauldie, and R. Fritsché. 1999. Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to β-lactoglobulin. Immunology 96:278-285.
26. Pessi, T., Y. Sutas, A. Marttinen, and E. Isolauri. 1998. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J. Nutr. 128:2313-2318.
27. Satter, M. A., K. Sakai, S. Ahmed, K. Yoshino, S. Yamamoto, Y. Shimizu, and F. Ota. 2002. Low-protein diet induces oral tolerance to ovalbumin in mice. J. Nutr. Sci. Vitaminol. 48:51-58.
28. Shroff, K. E., K. Meslin, and J. J. Cebra. 1995. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63:3904-3913.
29. Spahn, T. W., A. Fontana, A. M. Faria, A. J. Slavin, H.-P. Eugster, X. Zhang, P. A. Koni, N. H. Ruddle, R. A. Flavell, P. D. Rennert, and H. L. Weiner. 2001. Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur. J. Immunol. 31:1278-1287.
30. Strobel, S., and A. Ferguson. 1987. Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology 60:317-318.
31. Sudo, N., S.-A. Sawamura, K. Tanaka, Y. Aiba, C. Kubo, and Y. Koga. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1739-1745.
32. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
33. Tsuji, R. F., K. Hoshimo, Y. Noro, N. M. Tsuji, T. Kurokawa, T. Masuda, S. Akira, and B. Nowak. 2003. Suppression of allergic reaction by λ-carrageenan: Toll-like receptor 4/MyD88-dependent and -independent modulation of immunity. Clin. Exp. Allergy 33:249-258.
34. + T cells with low proliferative capacity that produce transforming growth factor β and interleukin-10. Clin. Diagn. Lab. Immunol. 8:695-701.
35. Wannemuehler, M. J., H. Kiyono, J. L. Babb, S. M. Michalek, and J. R. McGhee. 1982. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J. Immunol. 129:959-965.